Skip to main content
Top
Published in: Inflammation 1/2015

01-02-2015

Single Nucleotide Polymorphisms of Toll-Like Receptor 7 in Hepatitis C Virus Infection Patients from a High-Risk Chinese Population

Authors: Xing-xin Xue, Jian-ming Gong, Shai-di Tang, Chun-fang Gao, Jia-jia Wang, Li Cai, Jie Wang, Rong-bin Yu, Zhi-hang Peng, Nai-jun Fan, Chang-jun Wang, Jin Zhu, Yun Zhang

Published in: Inflammation | Issue 1/2015

Login to get access

Abstract

Hepatitis C virus (HCV) infection varies in the outcomes depending on both viral and host factors. This study aims to investigate the associations of three single nucleotide polymorphisms (SNPs) of Toll-like receptor 7 (TLR7), rs179016, rs5743733, and rs1634323, with susceptibility to HCV infection and clearance. The three SNPs were genotyped in a high-risk Chinese population, including 444 HCV spontaneous clearance cases, 732 persistent infection cases, and 1107 healthy controls. The G allele of rs1634323 was related to the protection from persistent infection among females (dominant model: odds ratio (OR) = 0.558, 95 % confidence interval (CI) = 0.348–0.894, P = 0.015). This protective effect was more evident in blood donation and HCV non-1 genotype-infected subgroups (all P < 0.05). The carriage of rs179016 C allele was more prone to develop persistent infection (OR = 1.444, 95 % CI = 1.096–1.903, P = 0.009) in males, and the risk effect remained significant among older (>50 years), hemodialysis (HD), and HCV-1 and HCV non-1 genotypes-infected subjects (all P < 0.05). Haplotype analyses showed that CCA haplotype among females was correlated with the elevated risk of HCV susceptibility while the carriage of GGA was more prone to be infected with HCV and CCA was more likely to develop persistent infection (all P < 0.05) among males. Our results first demonstrated that the carriage of rs179016 C allele had a negative effect on spontaneous clearance of HCV among males while rs1634323 G allele conferred a protective effect against persistent infection among female subjects.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sakoman, S. 2009. Prevention and treatment of hepatitis C in illicit drug users. Acta Medica Croatica 63(5): 437–442.PubMed Sakoman, S. 2009. Prevention and treatment of hepatitis C in illicit drug users. Acta Medica Croatica 63(5): 437–442.PubMed
2.
go back to reference Morgan, R.L., B. Baack, B.D. Smith, A. Yartel, M. Pitasi, and Y. Falck-Ytter. 2013. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Annals of Internal Medicine 158: 329–337.CrossRefPubMed Morgan, R.L., B. Baack, B.D. Smith, A. Yartel, M. Pitasi, and Y. Falck-Ytter. 2013. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Annals of Internal Medicine 158: 329–337.CrossRefPubMed
3.
go back to reference Gao, X., Q. Cui, X. Shi, J. Su, Z. Peng, X. Chen, N. Lei, K. Ding, L. Wang, R. Yu, and N. Wang. 2011. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infectious Diseases 11: 88.CrossRefPubMedCentralPubMed Gao, X., Q. Cui, X. Shi, J. Su, Z. Peng, X. Chen, N. Lei, K. Ding, L. Wang, R. Yu, and N. Wang. 2011. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infectious Diseases 11: 88.CrossRefPubMedCentralPubMed
4.
go back to reference Cui, Y., and J. Jia. 2013. Update on epidemiology of hepatitis B and C in China. Journal of Gastroenterology and Hepatology 28(Suppl 1): 7–10.CrossRefPubMed Cui, Y., and J. Jia. 2013. Update on epidemiology of hepatitis B and C in China. Journal of Gastroenterology and Hepatology 28(Suppl 1): 7–10.CrossRefPubMed
5.
go back to reference Cheng, P.L., H.L. Eng, M.H. Chou, H.L. You, and T.M. Lin. 2007. Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. Translational Research 150: 311–318.CrossRefPubMed Cheng, P.L., H.L. Eng, M.H. Chou, H.L. You, and T.M. Lin. 2007. Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. Translational Research 150: 311–318.CrossRefPubMed
6.
go back to reference Diebold, S.S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529–1531.CrossRefPubMed Diebold, S.S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529–1531.CrossRefPubMed
7.
go back to reference Horsmans, Y., T. Berg, J.P. Desager, T. Mueller, E. Schott, S.P. Fletcher, K.R. Steffy, L.A. Bauman, B.M. Kerr, and D.R. Averett. 2005. Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection. Hepatology 42: 724–731.CrossRefPubMed Horsmans, Y., T. Berg, J.P. Desager, T. Mueller, E. Schott, S.P. Fletcher, K.R. Steffy, L.A. Bauman, B.M. Kerr, and D.R. Averett. 2005. Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection. Hepatology 42: 724–731.CrossRefPubMed
8.
go back to reference Lee, J., C.C. Wu, K.J. Lee, T.H. Chuang, K. Katakura, Y.T. Liu, M. Chan, R. Tawatao, M. Chung, C. Shen, H.B. Cottam, M.M. Lai, E. Raz, and D.A. Carson. 2006. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proceedings of the National Academy of Sciences of the United States of America 103: 1828–1833.CrossRefPubMedCentralPubMed Lee, J., C.C. Wu, K.J. Lee, T.H. Chuang, K. Katakura, Y.T. Liu, M. Chan, R. Tawatao, M. Chung, C. Shen, H.B. Cottam, M.M. Lai, E. Raz, and D.A. Carson. 2006. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proceedings of the National Academy of Sciences of the United States of America 103: 1828–1833.CrossRefPubMedCentralPubMed
9.
go back to reference Schott, E., H. Witt, K. Neumann, S. Taube, D.Y. Oh, E. Schreier, S. Vierich, G. Puhl, A. Bergk, J. Halangk, V. Weich, B. Wiedenmann, and T. Berg. 2007. A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection. Journal of Hepatology 47: 203–211.CrossRefPubMed Schott, E., H. Witt, K. Neumann, S. Taube, D.Y. Oh, E. Schreier, S. Vierich, G. Puhl, A. Bergk, J. Halangk, V. Weich, B. Wiedenmann, and T. Berg. 2007. A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection. Journal of Hepatology 47: 203–211.CrossRefPubMed
10.
go back to reference Netea, M.G., C. Wijmenga, and L.A. O'Neill. 2012. Genetic variation in Toll-like receptors and disease susceptibility. Nature Immunology 13: 535–542.CrossRefPubMed Netea, M.G., C. Wijmenga, and L.A. O'Neill. 2012. Genetic variation in Toll-like receptors and disease susceptibility. Nature Immunology 13: 535–542.CrossRefPubMed
11.
go back to reference Oh, D.Y., K. Baumann, O. Hamouda, J.K. Eckert, K. Neumann, C. Kücherer, B. Bartmeyer, G. Poggensee, N. Oh, A. Pruss, H. Jessen, and R.R. Schumann. 2009. A frequent functional Toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS 23: 297–307.CrossRefPubMed Oh, D.Y., K. Baumann, O. Hamouda, J.K. Eckert, K. Neumann, C. Kücherer, B. Bartmeyer, G. Poggensee, N. Oh, A. Pruss, H. Jessen, and R.R. Schumann. 2009. A frequent functional Toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS 23: 297–307.CrossRefPubMed
12.
go back to reference Shen, N., Q. Fu, Y. Deng, X. Qian, J. Zhao, K.M. Kaufman, Y.L. Wu, C.Y. Yu, Y. Tang, J.Y. Chen, W. Yang, M. Wong, A. Kawasaki, N. Tsuchiya, T. Sumida, Y. Kawaguchi, H.S. Howe, M.Y. Mok, S.Y. Bang, F.L. Liu, D.M. Chang, Y. Takasaki, H. Hashimoto, J.B. Harley, J.M. Guthridge, J.M. Grossman, R.M. Cantor, Y.W. Song, S.C. Bae, S. Chen, B.H. Hahn, Y.L. Lau, and B.P. Tsao. 2010. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America 107: 15838–15843.CrossRefPubMedCentralPubMed Shen, N., Q. Fu, Y. Deng, X. Qian, J. Zhao, K.M. Kaufman, Y.L. Wu, C.Y. Yu, Y. Tang, J.Y. Chen, W. Yang, M. Wong, A. Kawasaki, N. Tsuchiya, T. Sumida, Y. Kawaguchi, H.S. Howe, M.Y. Mok, S.Y. Bang, F.L. Liu, D.M. Chang, Y. Takasaki, H. Hashimoto, J.B. Harley, J.M. Guthridge, J.M. Grossman, R.M. Cantor, Y.W. Song, S.C. Bae, S. Chen, B.H. Hahn, Y.L. Lau, and B.P. Tsao. 2010. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America 107: 15838–15843.CrossRefPubMedCentralPubMed
13.
go back to reference dos Santos, B.P., J.V. Valverde, P. Rohr, O.A. Monticielo, J.C. Brenol, R.M. Xavier, and J.A. Chies. 2012. TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from southern Brazil. Lupus 21: 302–309.CrossRefPubMed dos Santos, B.P., J.V. Valverde, P. Rohr, O.A. Monticielo, J.C. Brenol, R.M. Xavier, and J.A. Chies. 2012. TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from southern Brazil. Lupus 21: 302–309.CrossRefPubMed
14.
go back to reference Nilsson, D., A.K. Andiappan, C. Hallden, W. De Yun, T. Sall, C.F. Tim, and L.O. Cardell. 2012. Toll-like receptor gene polymorphisms are associated with allergic rhinitis: a case control study. BMC Medical Genetics 13: 66.CrossRefPubMedCentralPubMed Nilsson, D., A.K. Andiappan, C. Hallden, W. De Yun, T. Sall, C.F. Tim, and L.O. Cardell. 2012. Toll-like receptor gene polymorphisms are associated with allergic rhinitis: a case control study. BMC Medical Genetics 13: 66.CrossRefPubMedCentralPubMed
15.
go back to reference Simmonds, P., F. McOmish, P.L. Yap, S.W. Chan, C.K. Lin, G. Dusheiko, A.A. Saeed, and E.C. Holmes. 1993. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. Journal of General Virology 74: 661–668.CrossRefPubMed Simmonds, P., F. McOmish, P.L. Yap, S.W. Chan, C.K. Lin, G. Dusheiko, A.A. Saeed, and E.C. Holmes. 1993. Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. Journal of General Virology 74: 661–668.CrossRefPubMed
16.
go back to reference Bhattacherjee, V., L.E. Prescott, I. Pike, B. Rodgers, H. Bell, A.R. El-Zayadi, M.C. Kew, J. Conradie, C.K. Lin, H. Marsden, A.A. Saeed, D. Parker, P.H. Yap, and P. Simmonds. 1995. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. Journal of General Virology 76: 1737–1748.CrossRefPubMed Bhattacherjee, V., L.E. Prescott, I. Pike, B. Rodgers, H. Bell, A.R. El-Zayadi, M.C. Kew, J. Conradie, C.K. Lin, H. Marsden, A.A. Saeed, D. Parker, P.H. Yap, and P. Simmonds. 1995. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. Journal of General Virology 76: 1737–1748.CrossRefPubMed
17.
go back to reference Sada, T., M. Ota, Y. Katsuyama, A. Meguro, E. Nomura, R. Uemoto, T. Nishide, E. Okada, S. Ohno, H. Inoko, and N. Mizuki. 2011. Association analysis of Toll-like receptor 7 gene polymorphisms and Behcet's disease in Japanese patients. Human Immunology 72: 269–272.CrossRefPubMed Sada, T., M. Ota, Y. Katsuyama, A. Meguro, E. Nomura, R. Uemoto, T. Nishide, E. Okada, S. Ohno, H. Inoko, and N. Mizuki. 2011. Association analysis of Toll-like receptor 7 gene polymorphisms and Behcet's disease in Japanese patients. Human Immunology 72: 269–272.CrossRefPubMed
18.
go back to reference Tian, J., Y. Ma, J. Li, H. Cen, D.G. Wang, C.C. Feng, R.J. Li, R.X. Leng, H.F. Pan, and D.Q. Ye. 2012. The TLR7 7926A > G polymorphism is associated with susceptibility to systemic lupus erythematosus. Molecular Medicine Reports 6: 105–110.PubMed Tian, J., Y. Ma, J. Li, H. Cen, D.G. Wang, C.C. Feng, R.J. Li, R.X. Leng, H.F. Pan, and D.Q. Ye. 2012. The TLR7 7926A > G polymorphism is associated with susceptibility to systemic lupus erythematosus. Molecular Medicine Reports 6: 105–110.PubMed
19.
go back to reference Stephens, M., and P. Donnelly. 2003. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. American Journal of Human Genetics 73: 1162–1169.CrossRefPubMedCentralPubMed Stephens, M., and P. Donnelly. 2003. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. American Journal of Human Genetics 73: 1162–1169.CrossRefPubMedCentralPubMed
20.
go back to reference Seki, E., and D.A. Brenner. 2008. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48: 322–335.CrossRefPubMed Seki, E., and D.A. Brenner. 2008. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48: 322–335.CrossRefPubMed
21.
go back to reference Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. Journal of Immunology 168: 4531–4537.CrossRef Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. Journal of Immunology 168: 4531–4537.CrossRef
22.
go back to reference Askar, E., G. Ramadori, and S. Mihm. 2010. Toll-like receptor 7 rs179008/Gln11Leu gene variants in chronic hepatitis C virus infection. Journal of Medical Virology 82: 1859–1868.CrossRefPubMed Askar, E., G. Ramadori, and S. Mihm. 2010. Toll-like receptor 7 rs179008/Gln11Leu gene variants in chronic hepatitis C virus infection. Journal of Medical Virology 82: 1859–1868.CrossRefPubMed
23.
go back to reference Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunology 2: 675–680.CrossRefPubMed Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunology 2: 675–680.CrossRefPubMed
24.
go back to reference Abe, T., Y. Kaname, I. Hamamoto, Y. Tsuda, X. Wen, S. Taguwa, K. Moriishi, O. Takeuchi, T. Kawai, T. Kanto, N. Hayashi, S. Akira, and Y. Matsuura. 2007. Hepatitis C virus nonstructural protein 5A modulates the Toll-likereceptor-MyD88-dependent signaling pathway in macrophage cell lines. Journal of Virology 81: 8953–8966.CrossRefPubMedCentralPubMed Abe, T., Y. Kaname, I. Hamamoto, Y. Tsuda, X. Wen, S. Taguwa, K. Moriishi, O. Takeuchi, T. Kawai, T. Kanto, N. Hayashi, S. Akira, and Y. Matsuura. 2007. Hepatitis C virus nonstructural protein 5A modulates the Toll-likereceptor-MyD88-dependent signaling pathway in macrophage cell lines. Journal of Virology 81: 8953–8966.CrossRefPubMedCentralPubMed
25.
go back to reference Jones, H.M., P.L. Chan, P.H. van der Graaf, and R. Webster. 2012. Use of modelling and simulation techniques to support decision making on the progression of PF-04878691, a TLR7 agonist being developed for hepatitis C. British Journal of Clinical Pharmacology 73: 77–92.CrossRefPubMedCentralPubMed Jones, H.M., P.L. Chan, P.H. van der Graaf, and R. Webster. 2012. Use of modelling and simulation techniques to support decision making on the progression of PF-04878691, a TLR7 agonist being developed for hepatitis C. British Journal of Clinical Pharmacology 73: 77–92.CrossRefPubMedCentralPubMed
26.
go back to reference Pockros, P.J., D. Guyader, H. Patton, M.J. Tong, T. Wright, J.G. McHutchison, and T.C. Meng. 2007. Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies. Journal of Hepatology 47: 174–182.CrossRefPubMed Pockros, P.J., D. Guyader, H. Patton, M.J. Tong, T. Wright, J.G. McHutchison, and T.C. Meng. 2007. Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies. Journal of Hepatology 47: 174–182.CrossRefPubMed
27.
go back to reference Nagahara, K., J.D. Anderson, G.D. Kini, N.K. Dalley, S.B. Larson, D.F. Smee, A. Jin, B.S. Sharma, W.B. Jolley, and R.K. Robins. 1990. Thiazolo[4,5-d]pyrimidine nucleosides. The synthesis of certain 3-beta-D-ribofuranosylthiazolo[4,5-d]pyrimidines as potential immunotherapeutic agents. Journal of Medicinal Chemistry 33: 407–415.CrossRefPubMed Nagahara, K., J.D. Anderson, G.D. Kini, N.K. Dalley, S.B. Larson, D.F. Smee, A. Jin, B.S. Sharma, W.B. Jolley, and R.K. Robins. 1990. Thiazolo[4,5-d]pyrimidine nucleosides. The synthesis of certain 3-beta-D-ribofuranosylthiazolo[4,5-d]pyrimidines as potential immunotherapeutic agents. Journal of Medicinal Chemistry 33: 407–415.CrossRefPubMed
28.
go back to reference Smee, D.F., J.H. Huffman, A.C. Gessaman, J.W. Huggins, and R.W. Sidwell. 1991. Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice. Antiviral Research 15: 229–239.CrossRefPubMed Smee, D.F., J.H. Huffman, A.C. Gessaman, J.W. Huggins, and R.W. Sidwell. 1991. Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice. Antiviral Research 15: 229–239.CrossRefPubMed
29.
go back to reference Gorden, K.B., K.S. Gorski, S.J. Gibson, R.M. Kedl, W.C. Kieper, X. Qiu, M.A. Tomai, S.S. Alkan, and J.P. Vasilakos. 2005. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. Journal of Immunology 174: 1259–1268.CrossRef Gorden, K.B., K.S. Gorski, S.J. Gibson, R.M. Kedl, W.C. Kieper, X. Qiu, M.A. Tomai, S.S. Alkan, and J.P. Vasilakos. 2005. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. Journal of Immunology 174: 1259–1268.CrossRef
30.
go back to reference Rauch, A., S. Gaudieri, C. Thio, and P.Y. Bochud. 2009. Host genetic determinants of spontaneous hepatitis C clearance. Pharmacogenomics 10: 1819–1837.CrossRefPubMed Rauch, A., S. Gaudieri, C. Thio, and P.Y. Bochud. 2009. Host genetic determinants of spontaneous hepatitis C clearance. Pharmacogenomics 10: 1819–1837.CrossRefPubMed
31.
go back to reference Wang, C.H., H.L. Eng, K.H. Lin, C.H. Chang, C.A. Hsieh, Y.L. Lin, and T.M. Lin. 2011. TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection. PLoS ONE 6: e26235.CrossRefPubMedCentralPubMed Wang, C.H., H.L. Eng, K.H. Lin, C.H. Chang, C.A. Hsieh, Y.L. Lin, and T.M. Lin. 2011. TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection. PLoS ONE 6: e26235.CrossRefPubMedCentralPubMed
32.
go back to reference Wei, X.S., C.D. Wei, Y.Q. Tong, C.L. Zhu, and P.A. Zhang. 2014. Single nucleotide polymorphisms of Toll-like receptor 7 and Toll-like receptor 9 in hepatitis C virus infection patients from Central China. Yonsei Medical Journal 55: 428–434.CrossRefPubMedCentralPubMed Wei, X.S., C.D. Wei, Y.Q. Tong, C.L. Zhu, and P.A. Zhang. 2014. Single nucleotide polymorphisms of Toll-like receptor 7 and Toll-like receptor 9 in hepatitis C virus infection patients from Central China. Yonsei Medical Journal 55: 428–434.CrossRefPubMedCentralPubMed
33.
go back to reference Schott, E., H. Witt, K. Neumann, A. Bergk, J. Halangk, V. Weich, T. Müller, G. Puhl, B. Wiedenmann, and T. Berg. 2008. Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy. Journal of Viral Hepatitis 15: 71–78.PubMed Schott, E., H. Witt, K. Neumann, A. Bergk, J. Halangk, V. Weich, T. Müller, G. Puhl, B. Wiedenmann, and T. Berg. 2008. Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy. Journal of Viral Hepatitis 15: 71–78.PubMed
34.
go back to reference Cui, Q., Y.X. Zhang, J. Su, X. Chen, K. Ding, N. Lei, Y. Liu, J. Li, Y. Zhang, and R.B. Yu. 2011. Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population. Infection, Genetics and Evolution 11: 1682–1689.CrossRefPubMed Cui, Q., Y.X. Zhang, J. Su, X. Chen, K. Ding, N. Lei, Y. Liu, J. Li, Y. Zhang, and R.B. Yu. 2011. Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population. Infection, Genetics and Evolution 11: 1682–1689.CrossRefPubMed
Metadata
Title
Single Nucleotide Polymorphisms of Toll-Like Receptor 7 in Hepatitis C Virus Infection Patients from a High-Risk Chinese Population
Authors
Xing-xin Xue
Jian-ming Gong
Shai-di Tang
Chun-fang Gao
Jia-jia Wang
Li Cai
Jie Wang
Rong-bin Yu
Zhi-hang Peng
Nai-jun Fan
Chang-jun Wang
Jin Zhu
Yun Zhang
Publication date
01-02-2015
Publisher
Springer US
Published in
Inflammation / Issue 1/2015
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-0016-x

Other articles of this Issue 1/2015

Inflammation 1/2015 Go to the issue